nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—ADRA1B—polycystic ovary syndrome	0.886	1	CbGaD
Propericiazine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.000442	0.0677	CrCbGaD
Propericiazine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.000432	0.0662	CrCbGaD
Propericiazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.000414	0.0634	CrCbGaD
Propericiazine—Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.000354	0.0543	CrCbGaD
Propericiazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.000353	0.0541	CrCbGaD
Propericiazine—Quetiapine—ADRA1D—polycystic ovary syndrome	0.000334	0.0511	CrCbGaD
Propericiazine—Zuclopenthixol—ADRA1A—polycystic ovary syndrome	0.000332	0.0508	CrCbGaD
Propericiazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.000316	0.0485	CrCbGaD
Propericiazine—Promazine—ADRA1D—polycystic ovary syndrome	0.000307	0.047	CrCbGaD
Propericiazine—Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.000302	0.0463	CrCbGaD
Propericiazine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.000297	0.0456	CrCbGaD
Propericiazine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.000291	0.0446	CrCbGaD
Propericiazine—Quetiapine—ADRA1B—polycystic ovary syndrome	0.000285	0.0436	CrCbGaD
Propericiazine—Promazine—ADRA1B—polycystic ovary syndrome	0.000262	0.0401	CrCbGaD
Propericiazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.000238	0.0364	CrCbGaD
Propericiazine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.00023	0.0353	CrCbGaD
Propericiazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.000213	0.0326	CrCbGaD
Propericiazine—Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.000203	0.0312	CrCbGaD
Propericiazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.0002	0.0307	CrCbGaD
Propericiazine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.000198	0.0303	CrCbGaD
Propericiazine—Quetiapine—ADRA1A—polycystic ovary syndrome	0.000192	0.0294	CrCbGaD
Propericiazine—Promazine—ADRA1A—polycystic ovary syndrome	0.000176	0.027	CrCbGaD
Propericiazine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.000155	0.0238	CrCbGaD
Propericiazine—DRD1—Signaling Pathways—PTGER3—polycystic ovary syndrome	6.93e-05	0.000642	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LHCGR—polycystic ovary syndrome	6.93e-05	0.000642	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	6.82e-05	0.000631	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NPB—polycystic ovary syndrome	6.8e-05	0.00063	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—LHB—polycystic ovary syndrome	6.73e-05	0.000624	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	6.68e-05	0.000618	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	6.58e-05	0.00061	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	6.52e-05	0.000604	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—ADRB2—polycystic ovary syndrome	6.51e-05	0.000603	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—GHRL—polycystic ovary syndrome	6.49e-05	0.000601	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTAFR—polycystic ovary syndrome	6.48e-05	0.0006	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	6.43e-05	0.000596	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FLT4—polycystic ovary syndrome	6.42e-05	0.000595	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	6.39e-05	0.000592	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	6.37e-05	0.00059	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—SCT—polycystic ovary syndrome	6.31e-05	0.000585	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.29e-05	0.000583	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADRB3—polycystic ovary syndrome	6.19e-05	0.000573	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.15e-05	0.000569	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.12e-05	0.000567	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—LHB—polycystic ovary syndrome	6.12e-05	0.000566	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKR1C2—polycystic ovary syndrome	6.07e-05	0.000562	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TEAD2—polycystic ovary syndrome	6.07e-05	0.000562	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—GNAS—polycystic ovary syndrome	6.04e-05	0.000559	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	6.02e-05	0.000558	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—GNRH1—polycystic ovary syndrome	5.98e-05	0.000554	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INHBB—polycystic ovary syndrome	5.96e-05	0.000552	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	5.84e-05	0.000541	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PLAT—polycystic ovary syndrome	5.81e-05	0.000538	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—FSHR—polycystic ovary syndrome	5.8e-05	0.000537	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—SCT—polycystic ovary syndrome	5.73e-05	0.000531	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTGER3—polycystic ovary syndrome	5.67e-05	0.000526	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LHCGR—polycystic ovary syndrome	5.67e-05	0.000526	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	5.63e-05	0.000521	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NPB—polycystic ovary syndrome	5.61e-05	0.00052	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	5.6e-05	0.000519	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	5.6e-05	0.000518	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.57e-05	0.000516	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—LHB—polycystic ovary syndrome	5.56e-05	0.000515	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—POMC—polycystic ovary syndrome	5.54e-05	0.000513	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	5.47e-05	0.000506	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	5.43e-05	0.000503	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.43e-05	0.000503	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	5.38e-05	0.000498	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.34e-05	0.000495	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	5.32e-05	0.000493	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.31e-05	0.000492	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	5.31e-05	0.000492	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—SCT—polycystic ovary syndrome	5.21e-05	0.000482	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.15e-05	0.000477	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	5.11e-05	0.000473	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PNPLA2—polycystic ovary syndrome	5.09e-05	0.000471	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	5.07e-05	0.00047	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FSHR—polycystic ovary syndrome	5.07e-05	0.00047	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—LHB—polycystic ovary syndrome	5.05e-05	0.000468	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—GNAS—polycystic ovary syndrome	4.98e-05	0.000462	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	4.97e-05	0.00046	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—POMC—polycystic ovary syndrome	4.97e-05	0.00046	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	4.93e-05	0.000457	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.93e-05	0.000457	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INHBB—polycystic ovary syndrome	4.88e-05	0.000452	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SRD5A1—polycystic ovary syndrome	4.82e-05	0.000447	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.77e-05	0.000442	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—SCT—polycystic ovary syndrome	4.73e-05	0.000438	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	4.68e-05	0.000434	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	4.68e-05	0.000434	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.64e-05	0.00043	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—STAR—polycystic ovary syndrome	4.6e-05	0.000426	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.56e-05	0.000422	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FST—polycystic ovary syndrome	4.52e-05	0.000419	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	4.51e-05	0.000418	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.49e-05	0.000416	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.46e-05	0.000414	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—GNAS—polycystic ovary syndrome	4.46e-05	0.000413	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.45e-05	0.000412	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LHB—polycystic ovary syndrome	4.41e-05	0.000409	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	4.41e-05	0.000408	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	4.38e-05	0.000406	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.31e-05	0.000399	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	4.25e-05	0.000394	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.18e-05	0.000387	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.17e-05	0.000386	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FSHR—polycystic ovary syndrome	4.15e-05	0.000385	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.14e-05	0.000383	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SCT—polycystic ovary syndrome	4.13e-05	0.000383	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HMMR—polycystic ovary syndrome	4.1e-05	0.00038	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.08e-05	0.000378	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—POMC—polycystic ovary syndrome	4.07e-05	0.000377	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—IL6—polycystic ovary syndrome	4.04e-05	0.000374	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.04e-05	0.000374	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	4.03e-05	0.000373	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.94e-05	0.000365	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HSD3B1—polycystic ovary syndrome	3.91e-05	0.000362	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.9e-05	0.000362	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	3.88e-05	0.000359	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	3.84e-05	0.000356	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.8e-05	0.000352	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.78e-05	0.000351	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.76e-05	0.000349	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FST—polycystic ovary syndrome	3.7e-05	0.000343	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.68e-05	0.000341	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.67e-05	0.00034	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	3.66e-05	0.000339	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.66e-05	0.000339	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LHB—polycystic ovary syndrome	3.61e-05	0.000335	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.59e-05	0.000332	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—LHB—polycystic ovary syndrome	3.57e-05	0.00033	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.54e-05	0.000328	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.53e-05	0.000327	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HSD3B2—polycystic ovary syndrome	3.49e-05	0.000323	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	3.43e-05	0.000317	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.42e-05	0.000317	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.41e-05	0.000316	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SCT—polycystic ovary syndrome	3.39e-05	0.000314	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INSR—polycystic ovary syndrome	3.38e-05	0.000313	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	3.38e-05	0.000313	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	3.36e-05	0.000311	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.34e-05	0.00031	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.33e-05	0.000309	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.23e-05	0.000299	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.22e-05	0.000298	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.22e-05	0.000298	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	3.17e-05	0.000294	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.16e-05	0.000293	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	3.15e-05	0.000292	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.13e-05	0.00029	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	3.13e-05	0.00029	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PGR—polycystic ovary syndrome	3.13e-05	0.00029	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	3.11e-05	0.000288	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.1e-05	0.000287	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	3.05e-05	0.000283	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.04e-05	0.000281	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.02e-05	0.00028	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	3.01e-05	0.000279	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	2.98e-05	0.000276	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.94e-05	0.000272	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.91e-05	0.00027	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.91e-05	0.00027	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.91e-05	0.00027	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	2.9e-05	0.000269	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.9e-05	0.000268	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	2.89e-05	0.000267	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	2.88e-05	0.000267	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.82e-05	0.000261	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.82e-05	0.000261	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.81e-05	0.00026	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	2.79e-05	0.000259	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	2.79e-05	0.000258	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.78e-05	0.000257	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	2.77e-05	0.000257	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.76e-05	0.000256	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	2.75e-05	0.000255	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	2.74e-05	0.000254	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.71e-05	0.000251	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.7e-05	0.00025	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.67e-05	0.000247	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.63e-05	0.000244	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.62e-05	0.000243	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	2.6e-05	0.000241	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.6e-05	0.000241	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.59e-05	0.00024	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	2.57e-05	0.000238	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.56e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	2.56e-05	0.000237	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.56e-05	0.000237	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.55e-05	0.000236	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PRL—polycystic ovary syndrome	2.54e-05	0.000235	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.45e-05	0.000227	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.43e-05	0.000225	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.41e-05	0.000223	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.39e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	2.39e-05	0.000221	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	2.39e-05	0.000221	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.3e-05	0.000213	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	2.29e-05	0.000212	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	2.28e-05	0.000211	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.24e-05	0.000207	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.22e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TH—polycystic ovary syndrome	2.21e-05	0.000205	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.21e-05	0.000205	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.17e-05	0.000201	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	2.15e-05	0.000199	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.14e-05	0.000198	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.13e-05	0.000197	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	2.12e-05	0.000196	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	2.1e-05	0.000195	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.09e-05	0.000194	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	2.09e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	2.08e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	2.02e-05	0.000188	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.01e-05	0.000186	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.97e-05	0.000183	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.97e-05	0.000182	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.97e-05	0.000182	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.9e-05	0.000176	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	1.89e-05	0.000175	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.88e-05	0.000174	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.83e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.83e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.82e-05	0.000169	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	1.81e-05	0.000167	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.79e-05	0.000166	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	1.75e-05	0.000162	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.74e-05	0.000162	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.73e-05	0.000161	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.72e-05	0.00016	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	1.72e-05	0.000159	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.72e-05	0.000159	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.71e-05	0.000159	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.66e-05	0.000153	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	1.63e-05	0.000151	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.63e-05	0.000151	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.56e-05	0.000145	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	1.52e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.51e-05	0.00014	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	1.51e-05	0.000139	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	1.5e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.47e-05	0.000136	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.45e-05	0.000134	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.45e-05	0.000134	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.44e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	1.43e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.41e-05	0.000131	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.37e-05	0.000127	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.28e-05	0.000119	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	1.23e-05	0.000114	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	1.23e-05	0.000114	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	1.23e-05	0.000114	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	1.22e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.21e-05	0.000112	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	1.21e-05	0.000112	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.19e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.18e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	1.18e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.13e-05	0.000104	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.11e-05	0.000103	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.06e-05	9.79e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	1.02e-05	9.42e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	1.01e-05	9.37e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	9.79e-06	9.06e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	9.78e-06	9.06e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.46e-06	8.76e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.29e-06	8.61e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	9.07e-06	8.4e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.75e-06	7.17e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.48e-06	6.93e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	6.54e-06	6.06e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.39e-06	5.92e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	5.36e-06	4.96e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	4.42e-06	4.09e-05	CbGpPWpGaD
